Burkitt Lymphoma
Showing 51 - 75 of 5,429
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma Trial in Minneapolis (drug, radiation, biological)
Recruiting
- Acute Leukemia
- +24 more
- Fludarabine
- +6 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Nov 4, 2021
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Terminated
- Adult Grade III Lymphomatoid Granulomatosis
- +116 more
- brentuximab vedotin
- +2 more
-
Chicago, Illinois
- +2 more
Aug 30, 2021
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +88 more
- bortezomib
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 14, 2021
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States
Completed
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- +5 more
- Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
- GVHD prophylaxis
-
Duarte, California
- +15 more
Nov 2, 2021
Adult Burkitt Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Burkitt Lymphoma, DLBCL
Active, not recruiting
- Adult Burkitt Lymphoma
- +4 more
- Cyclophosphamide
- +10 more
-
Chicago, Illinois
- +4 more
Feb 17, 2022
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,
Recruiting
- Acute Myelogenous Leukemia
- +17 more
- Allopurinol
- +8 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
May 21, 2021
Non-Hodgkin Lymphoma, Burkitt's Lymphoma, Chronic Lymphocytic Leukemia Trial in Italy, United Kingdom, United States (ADCT-402)
Completed
- Non-Hodgkin Lymphoma
- +8 more
-
La Jolla, California
- +10 more
Apr 27, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Burkitt Lymphoma Trial in Cincinnati (CPX-351)
Completed
- Acute Myeloid Leukemia
- +7 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Nov 6, 2020
Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (HSC835)
Completed
- Acute Myelocytic Leukemia
- +12 more
- HSC835
-
Minneapolis, MinnesotaNovartis Investigative Site
Dec 9, 2020
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)
Completed
- Lymphoma, Non-Hodgkin
- +2 more
-
Mwanza, Tanzania
- +5 more
May 21, 2020
Diffuse Large B Lymphoma (DLBCL), Follicular Lymphoma (FL), Mantle Cell Lymphoma (MCL) Trial in France (Real-life
Recruiting
- Diffuse Large B Lymphoma (DLBCL)
- +6 more
- Real-life epidemiological platform of lymphoma in France
-
Arras, France
- +36 more
Jun 25, 2021
Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Hematopoietic/Lymphoid Cancer
- +135 more
- beclomethasone dipropionate
- +4 more
-
Hackensack, New Jersey
- +1 more
Feb 1, 2021
Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies Trial in Minneapolis (Infusion of Treg)
Terminated
- Acute Lymphoblastic Leukemia
- +17 more
- Infusion of Treg
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Sep 8, 2020
Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, Burkitt Leukemia Trial in Houston (drug,
Completed
- Acute Lymphoblastic Leukemia
- +6 more
- Cyclophosphamide
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Apr 6, 2021
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +18 more
- everolimus
- +6 more
-
Scottsdale, Arizona
- +1 more
Sep 28, 2020
Ovarian Reserve in Younger Newly Diagnosed Lymphomas
Active, not recruiting
- Anaplastic Large Cell Lymphoma
- +4 more
- Laboratory Biomarker Analysis
- Questionnaire Administration
-
Birmingham, Alabama
- +106 more
Jan 11, 2023
High Grade B-Cell Lymphoma, Not Otherwise Specified, Recurrent Burkitt Lymphoma, Recurrent DLBCL Trial in New Brunswick
Withdrawn
- High Grade B-Cell Lymphoma, Not Otherwise Specified
- +6 more
- Bortezomib
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jun 12, 2020
ALL, Burkitt's Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (Rapamycin + high dose etoposide and cytarabine)
Terminated
- ALL
- +3 more
- Rapamycin + high dose etoposide and cytarabine
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Abramson Cancer Center
Apr 15, 2020
B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +9 more
-
Stanford, California
- +15 more
May 14, 2020
Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present, DLBCL Trial in Seattle (biological, procedure, drug, radiation, other)
Terminated
- Burkitt Lymphoma
- +6 more
- Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 30, 2020
Acute Leukemias, Burkitt's Lymphoma, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation, biological)
Terminated
- Acute Leukemias
- +2 more
- Fludarabine
- +3 more
-
Minneapolis, MinnesotaUniversity of Minnesota Masonic Cancer Center
Dec 12, 2019
Lymphoma, Large B-Cell, Diffuse, Burkitt Lymphoma Trial (Gallium citrate)
Withdrawn
- Lymphoma, Large B-Cell, Diffuse
- Burkitt Lymphoma
- Gallium citrate
- (no location specified)
Oct 8, 2019